Tumor promoter-dependent mouse leukemia cell line.

Area of Science:

• Oncology
• Cell Biology
• Biochemistry

Background:

• Thymic leukemias are aggressive cancers requiring better understanding of their growth mechanisms.
• Tumor promoters are critical in cancer development, but their specific cellular interactions are not fully elucidated.
• Developing novel in vitro models is essential for studying cancer biology and screening potential therapeutic agents.

Purpose of the Study:

• To establish and characterize a novel cell line dependent on tumor promoters for growth.
• To investigate the specific requirements for the in vitro proliferation of this new cell line.
• To assess the utility of this cell line as a model for screening tumor-promoting compounds and studying thymic leukemias.

Main Methods:

• Establishment of the A65T cell line from AKR/Ms thymic leukemia cultured with thymic epithelial cells.
• Culturing A65T cells in the presence of 12-O-tetradecanoylphorbol-13-acetate (TPA) and assessing growth dependency.
• Testing the growth-supporting capabilities of various compounds, including plant diterpene esters, indole alkaloids, polyacetates, cholera toxin, epidermal growth factor, and lymphokines (IL-2, IL-3).

Main Results:

• The A65T cell line demonstrated strict in vitro growth dependence on active tumor promoters, with reversibility upon withdrawal of TPA.
• Chemically diverse compounds with tumor-promoting activity in vivo, including plant diterpene esters, indole alkaloids, and polyacetates, supported A65T growth.
• Growth stimulation of A65T cells by these compounds correlated with their known tumor-promoting activity in mouse skin.
• Growth stimulators like cholera toxin and epidermal growth factor, as well as lymphokines (IL-2, IL-3), did not support A65T proliferation.
• TPA did not induce significant IL-2 or IL-3 production in A65T cells.

Conclusions:

• The A65T cell line is a valuable tool for screening environmental tumor promoters, particularly those interacting with the phorbol ester receptor.
• This cell line serves as a potential in vitro model for investigating the growth requirements of developing mouse thymic leukemias.
• The findings suggest a specific mechanism of tumor promoter-dependent growth in A65T cells, distinct from pathways involving common growth factors or lymphokines.